168 related articles for article (PubMed ID: 38115303)
21. Cardiac Dose Control and Optimization Strategy for Left Breast Cancer Radiotherapy With Non-Uniform VMAT Technology.
Qiu J; Zhang S; Lv B; Zheng X
Technol Cancer Res Treat; 2021; 20():15330338211053752. PubMed ID: 34806481
[No Abstract] [Full Text] [Related]
22. Influence of minimum segment width on intensity-modulated radiotherapy plan for left-sided breast cancer after breast conserving surgery.
Wang N; Chen L; Huang G; Sun H
Medicine (Baltimore); 2023 Nov; 102(46):e36064. PubMed ID: 37986375
[TBL] [Abstract][Full Text] [Related]
23. Robust optimization in lung treatment plans accounting for geometric uncertainty.
Zhang X; Rong Y; Morrill S; Fang J; Narayanasamy G; Galhardo E; Maraboyina S; Croft C; Xia F; Penagaricano J
J Appl Clin Med Phys; 2018 May; 19(3):19-26. PubMed ID: 29524301
[TBL] [Abstract][Full Text] [Related]
24. Tree-based exploration of the optimization objectives for automatic cervical cancer IMRT treatment planning.
Wang H; Wang R; Liu J; Zhang J; Yao K; Yue H; Zhang Y; You J; Wu H
Br J Radiol; 2021 Jul; 94(1123):20210214. PubMed ID: 34111955
[TBL] [Abstract][Full Text] [Related]
25. Volumetric-modulated arc therapy using multicriteria optimization for body and extremity sarcoma.
Young MR; Craft DL; Colbert CM; Remillard K; Vanbenthuysen L; Wang Y
J Appl Clin Med Phys; 2016 Nov; 17(6):283-291. PubMed ID: 27929501
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of fixed-jaw IMRT and tangential partial-VMAT radiotherapy plans for synchronous bilateral breast cancer irradiation based on a dosimetric study.
Huang JH; Wu XX; Lin X; Shi JT; Ma YJ; Duan S; Huang XB
J Appl Clin Med Phys; 2019 Sep; 20(9):31-41. PubMed ID: 31483573
[TBL] [Abstract][Full Text] [Related]
27. Dosimetric benefits of intensity-modulated radiotherapy and volumetric-modulated arc therapy in the treatment of postoperative cervical cancer patients.
Deng X; Han C; Chen S; Xie C; Yi J; Zhou Y; Zheng X; Deng Z; Jin X
J Appl Clin Med Phys; 2017 Jan; 18(1):25-31. PubMed ID: 28291936
[TBL] [Abstract][Full Text] [Related]
28. Clinical Impact of the Bolus in Intensity-Modulated Radiotherapy and Volumetric-Modulated Arc Therapy for Stage I-II Nasal Natural Killer/T-Cell Lymphoma.
Liu X; Wang Y; Guo Q; Luo H; Luo Q; Li Q; Wu Z; Jin F
Oncol Res Treat; 2020; 43(4):140-145. PubMed ID: 32018254
[TBL] [Abstract][Full Text] [Related]
29. Fan beam CT-guided online adaptive external radiotherapy of uterine cervical cancer: a dosimetric evaluation.
Peng H; Zhang J; Xu N; Zhou Y; Tan H; Ren T
BMC Cancer; 2023 Jun; 23(1):588. PubMed ID: 37365516
[TBL] [Abstract][Full Text] [Related]
30. [Serial tomotherapy vs. MLC-IMRT (multileaf collimator intensity modulated radiotherapy) for simultaneous boost treatment large intracerebral lesions].
Wolff D; Abo-Madyan Y; Dobler B; Lohr F; Mai S; Polednik M; Wenz F
Z Med Phys; 2009; 19(1):58-66. PubMed ID: 19459586
[TBL] [Abstract][Full Text] [Related]
31. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study.
Nicolini G; Ghosh-Laskar S; Shrivastava SK; Banerjee S; Chaudhary S; Agarwal JP; Munshi A; Clivio A; Fogliata A; Mancosu P; Vanetti E; Cozzi L
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):553-60. PubMed ID: 22386376
[TBL] [Abstract][Full Text] [Related]
32. Fixed-jaw technique to improve IMRT plan quality for the treatment of cervical and upper thoracic esophageal cancer.
Song W; Lu H; Liu J; Zhao D; Ma J; Zhang B; Yu D; Sun X; Li J
J Appl Clin Med Phys; 2019 Oct; 20(10):24-32. PubMed ID: 31460704
[TBL] [Abstract][Full Text] [Related]
33. A study of the dosimetric characteristics between different fixed-field IMRT and VMAT in early-stage primary mediastinal B-cell lymphoma.
Xu LM; Kang ML; Jiang B; Liu QF; Li YX
Med Dosim; 2018 Spring; 43(1):91-99. PubMed ID: 28935521
[TBL] [Abstract][Full Text] [Related]
34. Dosimetric analysis of intensity-modulated radiation therapy and volumetric-modulated arc therapy in comparison with conventional box technique in the treatment of carcinoma cervix: An impact of prosthetic implant.
Bhushan M; Tripathi D; Yadav G; Kumar L; Chowdhary RL; Pahuja AK; Suhail M; Mitra S; Gairola M
J Cancer Res Ther; 2022; 18(6):1504-1512. PubMed ID: 36412401
[TBL] [Abstract][Full Text] [Related]
35. Whole-pelvic radiotherapy with spot-scanning proton beams for uterine cervical cancer: a planning study.
Hashimoto S; Shibamoto Y; Iwata H; Ogino H; Shibata H; Toshito T; Sugie C; Mizoe JE
J Radiat Res; 2016 Sep; 57(5):524-532. PubMed ID: 27380800
[TBL] [Abstract][Full Text] [Related]
36. Optimising the dosimetric quality and efficiency of post-prostatectomy radiotherapy: a planning study comparing the performance of volumetric-modulated arc therapy (VMAT) with an optimised seven-field intensity-modulated radiotherapy (IMRT) technique.
Nguyen BT; Hornby C; Kron T; Cramb J; Rolfo A; Pham D; Haworth A; Tai KH; Foroudi F
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):211-9. PubMed ID: 22498196
[TBL] [Abstract][Full Text] [Related]
37. A treatment planning study comparing Elekta VMAT and fixed field IMRT using the varian treatment planning system eclipse.
Peters S; Schiefer H; Plasswilm L
Radiat Oncol; 2014 Jul; 9():153. PubMed ID: 25011529
[TBL] [Abstract][Full Text] [Related]
38. Volumetric-modulated arc therapy versus intensity-modulated radiotherapy for large volume retroperitoneal sarcomas: A comparative analysis of dosimetric and treatment delivery parameters.
Taggar AS; Graham D; Kurien E; Gräfe JL
J Appl Clin Med Phys; 2018 Jan; 19(1):276-281. PubMed ID: 29178585
[TBL] [Abstract][Full Text] [Related]
39. A comparative study of RapidArc and intensity-modulated radiotherapy plan quality for cervical cancer treatment.
Atiq A; Atiq M; Iqbal K; Sial MA; Altaf S; Shamsi QA; Buzdar SA
Indian J Cancer; 2018; 55(1):74-79. PubMed ID: 30147098
[TBL] [Abstract][Full Text] [Related]
40. Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT): trade-offs between secondary cancer induction risk and optimal target coverage.
Karpf D; Sakka M; Metzger M; Grabenbauer GG
Radiat Oncol; 2019 Sep; 14(1):156. PubMed ID: 31477165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
